Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONTRAST: Ciclesonide dose-finding in moderate to severe asthma
NCT01455194Phase 3Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2011
- Primary completion
- Aug 2014
- Modality
- Orthosteric Ligands
- Countries
- 5
01
Overview
A Phase 3 trial of ciclesonide in asthma, sponsored by AstraZeneca. Started Nov 2011; status: completed.
02
Drugs
ciclesonide
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01455194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01455194.